5th July 2023 (6 Topics)
1
Jul
3
Jul
4
Jul
5
Jul
6
Jul
7
Jul
8
Jul
10
Jul
11
Jul
12
Jul
13
Jul
14
Jul
15
Jul
17
Jul
18
Jul
19
Jul
20
Jul
21
Jul
22
Jul
24
Jul
25
Jul
26
Jul
27
Jul
28
Jul
29
Jul
31
Jul
5th July 2023
QUIZ - 5th July 2023
5 Questions
5 Minutes
Editorials
Context
In the relentless battle against highly drug resistant infections, a team of doctors recently witnessed a glimmer of hope amid the challenges they faced. An Indian innovation was made to deal with drug resistant pathogens.
Promising Antibiotics
- An Indian Innovation: A promising antibiotic, cefepime/zidebactam, developed by Indian researchers, combines two active components to combat drug-resistant gram-negative pathogens, including Pseudomonas aeruginosa.
- Made by Japan: Ce?derocol, a licenced antibiotic in several countries, developed by a Japanese company, has demonstrated excellent e?cacy against drug resistant infections.
- Emergency Use Authorisation (EUA): This extraordinary case underscores the urgent importance of granting EUA for antibiotics currently in phase 3 trials or licensed from other countries.
Challenges faced in dealing with drug resistant infections
- Limited effective choices- Doctors must navigate through a shrinking arsenal of e?ective antibiotics, leaving them with limited choices.
- Side effects- Often resorting to suboptimal treatments that may have signi?cant side e?ects or o?er little hope of a cure.
- Pressure build up- The constant race against time, trying to stay one step ahead of the mutating bacteria, adds to the immense pressure and helplessness experienced by doctors on the front lines.
Way Ahead
- Commitment- India, a nation that has demonstrated remarkable progress in granting EUA for COVID19 vaccines must show the same commitment in this field.
- Thoroughly Evaluated- We need antibiotics that have been thoroughly evaluated or proven to be e?ective are essential in the battle against superbugs.
- Doctor’s approval made mandatory- A collective decision by a team of experienced doctors, including infectious diseases experts should be made mandatory before utilizing these antibiotics.
You must be logged in to get greater insights. click here to login
Courses
Study
Notes
Home
Resources
More
